Belgium· BE-AMP-SAM269026-00
Enterol 250 mg
A saccharomyces boulardii product containing saccharomyces boulardii, registered in Belgium by Biocodex Benelux. The same ATC class is registered in 10 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Saccharomyces boulardii is registered in 10 of 19 countries.
Countries holding a registration under ATC A07FA02 (saccharomyces boulardii), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Saccharomyces boulardii · ATC A07FA02
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of saccharomyces boulardii costs, country by country.
Normalised to the WHO defined daily dose (1 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Saccharomyces boulardii · price per daily dose (1 g)
USD · FX 28 Sept 2026
- CH Switzerland$4.16
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Saccharomyces boulardii
- Manufacturer
- Biocodex Benelux
- Country
- Belgium (BE)
- ATC code
- A07FA02
- ATC class
- Saccharomyces boulardii
- Defined daily dose
- 1 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb2183002
- be_apb2183010
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Saccharomyces boulardii in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainULTRA-LEVURA 250 MG POLVO PARA SUSPENSION ORALBiocodex
- CzechiaENTEROLBIOCODEX, Gentilly
- FinlandPrecosaBiocodex
- PolandEnterolBIOCODEX
- GermanyBoulardii Pz Entsprechend Mindestens 10^10 Lebensfähige Zellen/G, LyophilisiertPharma Zentrale Gmbh
- United StatesA-34DNA Labs, Inc.
- United KingdomBiome Balance For those on Antibiotics 300mg capsulesLamberts Healthcare Ltd
- NorwayCodex 5 miliardiBiocodex
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Austria · Yomogi
- Cyprus · Bioflor
- Germany · Boulardii Pz Entsprechend Mindestens 10^10 Lebensfähige Zellen/G, Lyophilisiert, Ceritract
- Italy · Codex, Preparazione H
- Portugal · Prolif
- Sweden · Precosa
- Slovakia · Yomogi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aea981e4-3c43-405f-9675-19cffcdbf6f2 GET /v1/drugs/aea981e4-3c43-405f-9675-19cffcdbf6f2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for oral suspension",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Enterol 250 mg",
"name_fr": "Enterol 250 mg",
"name_nl": "Enterol 250 mg",
"amp_code": "SAM269026-00",
"strengths": [
"250.0000",
"471.9000",
"32.5000"
],
"pack_count": 4,
"substances": [
"Saccharomyces boulardii",
"Fructose",
"Lactose"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Saccharomyces Boulardii",
"authorisation_numbers": [
"BE269026"
]
}See everything about saccharomyces boulardii.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.